NDC product
Pain Relieving cleansing spary
NDC 69396-177 · Trifecta Pharmaceuticals USA, LLC.
Key facts
| Product NDC | 69396-177 |
|---|---|
| Proprietary name | Pain Relieving cleansing spary |
| Nonproprietary name | benzalkonium chloride and lidocaine HCI |
| Substances | BENZALKONIUM CHLORIDE, LIDOCAINE HYDROCHLORIDE |
| Dosage form | SPRAY |
| Route | TOPICAL |
| Labeler | Trifecta Pharmaceuticals USA, LLC. |
| Product type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Application number | M017 |
| Pharmacologic classes | Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE] |
| Marketing start | Jan 21, 2026 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: